Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Fisher Asset Management LLC Trims Position in Insulet Corporation $PODD
05:12am, Thursday, 04'th Dec 2025
Fisher Asset Management LLC decreased its holdings in shares of Insulet Corporation (NASDAQ: PODD) by 27.8% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fir
Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off
08:00am, Wednesday, 26'th Nov 2025
Our philosophy often runs counter to prevailing market sentiment, especially in times of excessive concentration and narrow market leadership. During this time, when many investors saw insulin pumps a
Looking for a Growth Stock? 3 Reasons Why Insulet (PODD) is a Solid Choice
01:46pm, Monday, 24'th Nov 2025
Insulet (PODD) could produce exceptional returns because of its solid growth attributes.
Insulet Corporation (PODD) Analyst/Investor Day Transcript
08:13pm, Thursday, 20'th Nov 2025
Insulet Corporation ( PODD ) Analyst/Investor Day November 20, 2025 9:00 AM EST Company Participants Clare Trachtman - Vice President of Investor Relations Ashley McEvoy - CEO, President & Director Er
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
12:30pm, Thursday, 20'th Nov 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, toda
3 Stocks With Upgraded Broker Ratings to Buy for Solid Returns
08:06am, Thursday, 20'th Nov 2025
Upgraded broker ratings bring the spotlight to PODD, SNDK and OI as potential picks in a selective market, each showing strong earnings growth and momentum.
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
10:45am, Tuesday, 18'th Nov 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 Medical Product Stocks to Watch From a Challenging Industry
10:21am, Monday, 17'th Nov 2025
The Zacks Medical products industry sees steady demand, but macro headwinds keep growth under pressure in 2025. BSX, PODD, BLFS and ALUR reflect the favorable fundamentals.
Why Insulet (PODD) Might be Well Poised for a Surge
01:21pm, Thursday, 13'th Nov 2025
Insulet (PODD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Best Momentum Stocks to Buy for Nov. 13
11:01am, Thursday, 13'th Nov 2025
FLEX, PODD and PRAA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Nov. 13, 2025.
Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
09:51am, Thursday, 13'th Nov 2025
PODD's Q3 earnings and revenues top forecasts, with strong Omnipod growth and margin expansion lifting shares.
New Strong Buy Stocks for Nov. 13: PODD, PRAA, and More
06:11am, Thursday, 13'th Nov 2025
PFBC, WFRD, PODD, PRAA and ALX have been added to the Zacks Rank #1 (Strong Buy) List on Nov. 13, 2025.
PODD Vs. Intuitive Surgical: This Underdog Might Just Win
02:15pm, Wednesday, 12'th Nov 2025
When it comes to surgical innovation, Intuitive Surgical (NASDAQ: ISRG) often dominates investor attention. But Insulet Corporation (NASDAQ: PODD), best known for its Omnipod insulin delivery system,
3 Top Momentum Stocks to Buy as U.S. Shutdown Nears End
04:01pm, Tuesday, 11'th Nov 2025
The Senate's move to end the record shutdown lifts Wall Street, spotlighting momentum stocks like Insulet, Celestica and Innodata.
Insulet (PODD) Upgraded to Strong Buy: Here's What You Should Know
01:03pm, Monday, 10'th Nov 2025
Insulet (PODD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
